"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente Medical Center - Hayward conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 37 clinical trials were completed, i.e. on average, 1850% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Medical Center - Hayward" #1 sponsor was "SWOG Cancer Research Network" with 13 trials, followed by "NSABP Foundation Inc" with 11 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Medical Center - Hayward" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Medical Center - Hayward" are "Breast Cancer" (18 trials), "HIV Infections" (7 trials), "Colorectal Cancer" (6 trials), "Lung Cancer" (5 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "Kaiser Permanente Medical Center - Hayward" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Medical Center - Hayward" are "Drug" (44 trials), "Biological" (12 trials), "Other" (11 trials), "Radiation" (7 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (8 trials), "Placebo" (6 trials), "placebo" (6 trials), "cyclophosphamide" (5 trials) and "fluorouracil" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Medical Center - Hayward" are 39 trials for "All" genders, 18 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Medical Center - Hayward". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Kaiser Permanente Medical Center - Hayward, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Medical Center - Hayward, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".